Background Image
Table of Contents Table of Contents
Previous Page  1374 / 1498 Next Page
Information
Show Menu
Previous Page 1374 / 1498 Next Page
Page Background

PFS: On study vs. last prior therapy

Patients at risk, n

125

60

33

22

12

4

125

40

14

9

5

2

1

Median PFS (months)

On study: 11.0

Last prior therapy: 4.6

PFS (%)

Time from start of idelalisib (months)